Pelthos Therapeutics Statistics
Total Valuation
PTHS has a market cap or net worth of $105.54 million. The enterprise value is $107.78 million.
Important Dates
The next confirmed earnings date is Thursday, November 13, 2025, before market open.
| Earnings Date | Nov 13, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
PTHS has 3.07 million shares outstanding. The number of shares has increased by 81.07% in one year.
| Current Share Class | 3.07M |
| Shares Outstanding | 3.07M |
| Shares Change (YoY) | +81.07% |
| Shares Change (QoQ) | +4.52% |
| Owned by Insiders (%) | 5.18% |
| Owned by Institutions (%) | 12.44% |
| Float | 1.14M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | 4.93 |
| PB Ratio | n/a |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio History Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.11
| Current Ratio | 0.11 |
| Quick Ratio | 0.01 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -17.78 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | -326.06% |
| Return on Invested Capital (ROIC) | n/a |
| Return on Capital Employed (ROCE) | 137.63% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$821,631 |
| Employee Count | 11 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Dividends & Yields
PTHS does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -81.07% |
| Shareholder Yield | -81.07% |
| Earnings Yield | -8.56% |
| FCF Yield | n/a |
Analyst Forecast
The average price target for PTHS is $50.00, which is 45.35% higher than the current price. The consensus rating is "Buy".
| Price Target | $50.00 |
| Price Target Difference | 45.35% |
| Analyst Consensus | Buy |
| Analyst Count | 1 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock Forecasts Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on July 2, 2025. It was a reverse split with a ratio of 1:10.
| Last Split Date | Jul 2, 2025 |
| Split Type | Reverse |
| Split Ratio | 1:10 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 1 |